Table 3.
Fluvoxamine dose at Time of First Activation and Dose at Week 8 among the 10 Subjects Who Developed Activationa
Subject | Week | Dose at time of first activation | End of study week | Dose at the end of the study (mg) |
---|---|---|---|---|
1 | 4 | 50 | 8 | 75 |
3 | 6 | 150 | 8 | 100 |
4 | 8 | 200 | 8 | 200 |
5 | 7 | 200 | 8 | 150 |
6 | 4 | 125 | 8 | 100 |
7 | 1 | 75 | 8 | 100 |
9 | 2 | 75 | 8 | 75 |
10 | 4 | 125 | 8 | 125 |
Two individuals (subjects 2 and 8) were omitted because they terminated the study before week 8.